AVE March 2024 Quarterly Activities Report & Appendix 4C 30/04/24 PRICE SENSITIVE download Created with Sketch. 318.85KB Share AVE Avecho commences Phase III insomnia trial 26/03/24 PRICE SENSITIVE download Created with Sketch. 202.98KB Share AVE Avecho meets TGA ahead of Phase III Clinical Trial 14/03/24 PRICE SENSITIVE download Created with Sketch. 67.34KB Share AVE AVE receives final ethics approval for Phase III CBD trial 07/03/24 PRICE SENSITIVE download Created with Sketch. 74.51KB Share AVE Appendix 4E and Annual Report 31 December 2023 29/02/24 PRICE SENSITIVE download Created with Sketch. 1.4MB Share AVE December 2023 Quarterly Activities Report & Appendix 4C 31/01/24 PRICE SENSITIVE download Created with Sketch. 299.59KB Share AVE September 2023 Quarterly Activities Report & Appendix 4C 31/10/23 PRICE SENSITIVE download Created with Sketch. 495.04KB Share AVE Appendix 4D and Half-year Financial Report 31/08/23 PRICE SENSITIVE download Created with Sketch. 1.37MB Share AVE Reinstatement to Official Quotation 28/08/23 PRICE SENSITIVE download Created with Sketch. 86.84KB Share AVE Avecho raises further $6M for Phase III trial 28/08/23 PRICE SENSITIVE download Created with Sketch. 91.03KB Share AVE Voluntary Suspension 25/08/23 PRICE SENSITIVE download Created with Sketch. 168.59KB Share AVE Trading Halt 23/08/23 PRICE SENSITIVE download Created with Sketch. 142.38KB Share AVE June 2023 Quarterly Activities Report & Appendix 4C 25/07/23 PRICE SENSITIVE download Created with Sketch. 268.38KB Share AVE AVE CBD capsule passes two-year stability milestone 22/06/23 PRICE SENSITIVE download Created with Sketch. 82.85KB Share AVE AVE adds TPM cannabinoid gummies to portfolio 07/06/23 PRICE SENSITIVE download Created with Sketch. 86.38KB Share AVE USPTO allows new TPM manufacturing patent 29/05/23 PRICE SENSITIVE download Created with Sketch. 79.48KB Share AVE Avecho licenses TPM for use in cancer drugs 22/05/23 PRICE SENSITIVE download Created with Sketch. 116.81KB Share AVE AVE commences manufacturing for Phase III trial 17/05/23 PRICE SENSITIVE download Created with Sketch. 283.12KB Share AVE Results of Entitlement Offer 09/05/23 PRICE SENSITIVE download Created with Sketch. 132.8KB Share AVE Receipt of R&D Tax Incentive 02/05/23 PRICE SENSITIVE download Created with Sketch. 201.89KB Share AVE March 2023 Quarterly Activities Report & Appendix 4C 28/04/23 PRICE SENSITIVE download Created with Sketch. 363.87KB Share AVE Investor Presentation 03/04/23 PRICE SENSITIVE download Created with Sketch. 1.68MB Share AVE Prospectus 03/04/23 PRICE SENSITIVE download Created with Sketch. 624.94KB Share AVE Entitlement Offer to raise $11m for Phase 3 clinical trial 03/04/23 PRICE SENSITIVE download Created with Sketch. 196.62KB Share AVE Appendix 4E - Preliminary Final Report 28/02/23 PRICE SENSITIVE download Created with Sketch. 182.16KB Share AVE Clinical CBD program expands with the Lambert Initiative 22/02/23 PRICE SENSITIVE download Created with Sketch. 78.69KB Share AVE December 2022 Quarterly Activities Report & Appendix 4C 31/01/23 PRICE SENSITIVE download Created with Sketch. 273.71KB Share AVE Athenex submits Avecho's phytonadione to FDA pre-IND 12/01/23 PRICE SENSITIVE download Created with Sketch. 238.19KB Share AVE Avecho receives ethics approval for Phase III CBD trial 22/12/22 PRICE SENSITIVE download Created with Sketch. 131.46KB Share AVE AVE signs development agreement with Perrigo 20/12/22 PRICE SENSITIVE download Created with Sketch. 269.72KB Share AVE September 2022 Quarterly Activities Report & Appendix 4C 28/10/22 PRICE SENSITIVE download Created with Sketch. 310.85KB Share AVE Increased CBD absorption in dogs vs commercial comparator 19/09/22 PRICE SENSITIVE download Created with Sketch. 85.86KB Share AVE Appendix 4D and Half-year Financial Report 29/08/22 PRICE SENSITIVE download Created with Sketch. 598.88KB Share AVE June 2022 Quarterly Activities Report & Appendix 4C 29/07/22 PRICE SENSITIVE download Created with Sketch. 176.18KB Share AVE Security Class Reinstatement to Quotation- AVEO 14/07/22 PRICE SENSITIVE download Created with Sketch. 86.31KB Share AVE Update on Listed Options and Federal Court Application 14/07/22 PRICE SENSITIVE download Created with Sketch. 239.84KB Share AVE Suspension from Official Quotation - AVEO 08/06/22 PRICE SENSITIVE download Created with Sketch. 148.32KB Share AVE Receipt of R&D Tax Incentive 03/05/22 PRICE SENSITIVE download Created with Sketch. 92.21KB Share AVE March 2022 Quarterly Activities Report & Appendix 4C 29/04/22 PRICE SENSITIVE download Created with Sketch. 142.17KB Share AVE Positive results from AVE's topical CBD pain study 29/03/22 PRICE SENSITIVE download Created with Sketch. 274.68KB Share AVE Dosing begins in topical CBD pain study 01/03/22 PRICE SENSITIVE download Created with Sketch. 93.08KB Share AVE Appendix 4E and Annual Report 31 December 2021 28/02/22 PRICE SENSITIVE download Created with Sketch. 1.38MB Share AVE AVE license agreement for US recreational cannabis market 02/02/22 PRICE SENSITIVE download Created with Sketch. 203.08KB Share AVE December 2021 Quarterly Activities Report & Appendix 4C 31/01/22 PRICE SENSITIVE download Created with Sketch. 294.5KB Share AVE AVE Licenses CBD Soft-Gel to Medterra Pharma for Arthritis 20/12/21 PRICE SENSITIVE download Created with Sketch. 214.39KB Share AVE Positive results from Avecho's Phase I trial of CBD soft-gel 08/12/21 PRICE SENSITIVE download Created with Sketch. 122.89KB Share AVE September 2021 Quarterly Activities Report & Appendix 4C 29/10/21 PRICE SENSITIVE download Created with Sketch. 754.33KB Share AVE Topical CBD pain study with Lambert Initiative approved 21/10/21 PRICE SENSITIVE download Created with Sketch. 151.27KB Share AVE Dosing begins in Phase I PK trial testing CBD soft-gel 04/10/21 PRICE SENSITIVE download Created with Sketch. 92.31KB Share AVE Phase I clinical trial testing CBD product-enrolment begins 15/09/21 PRICE SENSITIVE download Created with Sketch. 72.69KB Share AVE Appendix 4D and Half-year Financial Report 24/08/21 PRICE SENSITIVE download Created with Sketch. 921.78KB Share AVE June 2021 Quarterly Activities Report & Appendix 4C 27/07/21 PRICE SENSITIVE download Created with Sketch. 337.74KB Share AVE Avecho to Present New CBD Data at GCI Virtual Summit 08/06/21 PRICE SENSITIVE download Created with Sketch. 1.86MB Share AVE Chair's Address and CEO Presentation 31/05/21 PRICE SENSITIVE download Created with Sketch. 884.66KB Share AVE AB Vista to explore new TPM applications for Animal Health 31/05/21 PRICE SENSITIVE download Created with Sketch. 101.54KB Share AVE TGA meeting for CBD soft-gel targeting insomnia 26/05/21 PRICE SENSITIVE download Created with Sketch. 101.62KB Share AVE Avecho completes pharmaceutical CBD soft-gel product 21/05/21 PRICE SENSITIVE download Created with Sketch. 190.37KB Share AVE March 2021 Quarterly Activities Report & Appendix 4C 28/04/21 PRICE SENSITIVE download Created with Sketch. 396.86KB Share AVE Avecho receives ethics approval for CBD human trial 13/04/21 PRICE SENSITIVE download Created with Sketch. 78KB Share AVE Appendix 4E - Preliminary Final Report 26/02/21 PRICE SENSITIVE download Created with Sketch. 518.98KB Share AVE AVE receives firm commitment to raise $5.06 via placement 10/02/21 PRICE SENSITIVE download Created with Sketch. 112.33KB Share AVE Trading Halt 08/02/21 PRICE SENSITIVE download Created with Sketch. 217.82KB Share AVE December 2020 Quarterly Activities Report & Appendix 4C 29/01/21 PRICE SENSITIVE download Created with Sketch. 325.7KB Share AVE AVE begins Human Trial on CBD product 23/12/20 PRICE SENSITIVE download Created with Sketch. 192.01KB Share AVE Improved Propofol TPM Formulation Passes Toxicology Study 04/11/20 PRICE SENSITIVE download Created with Sketch. 77KB Share AVE September 2020 Quarterly Activities Report & Appendix 4C 28/10/20 PRICE SENSITIVE download Created with Sketch. 378.65KB Share AVE Response to ASX Price Query 26/10/20 PRICE SENSITIVE download Created with Sketch. 783.85KB Share AVE TPM Cannabinoid Development Program Update 19/10/20 PRICE SENSITIVE download Created with Sketch. 123.5KB Share AVE Receipt of R&D Tax Incentive 17/09/20 PRICE SENSITIVE download Created with Sketch. 61.58KB Share AVE Appendix 4D and Half-year Financial Report 28/08/20 PRICE SENSITIVE download Created with Sketch. 1.06MB Share AVE Progress Update for TPM Cannabinoid Development Program 20/08/20 PRICE SENSITIVE download Created with Sketch. 115.56KB Share AVE June 2020 Quarterly Activities Report & Appendix 4C 28/07/20 PRICE SENSITIVE download Created with Sketch. 326.06KB Share AVE Response to ASX Price Query 23/07/20 PRICE SENSITIVE download Created with Sketch. 267.8KB Share AVE March 2020 Quarterly Activities Report & Appendix 4C 29/04/20 PRICE SENSITIVE download Created with Sketch. 96.98KB Share AVE Changes to Leadership Team 27/04/20 PRICE SENSITIVE download Created with Sketch. 127.58KB Share AVE Medicinal cannabis supply agreement with Tasmanian Alkaloids 27/04/20 PRICE SENSITIVE download Created with Sketch. 141.67KB Share AVE Avecho signs Term Sheet for Cannabinoid Supply with Purisys 14/04/20 PRICE SENSITIVE download Created with Sketch. 73.99KB Share AVE Appendix 4E and Annual Report 31 December 2019 02/03/20 PRICE SENSITIVE download Created with Sketch. 1.43MB Share AVE Appendix 4C - Quarterly 23/01/20 PRICE SENSITIVE download Created with Sketch. 215.18KB Share AVE Injectable Portfolio Update - Products Differentiated by TPM 04/12/19 PRICE SENSITIVE download Created with Sketch. 1.19MB Share AVE Terumo return rights to TPM/Propofol Injectable 17/10/19 PRICE SENSITIVE download Created with Sketch. 63.87KB Share AVE Appendix 4C - Quarterly 10/10/19 PRICE SENSITIVE download Created with Sketch. 175.98KB Share AVE Appendix 4D and Half-year Financial Report 30/08/19 PRICE SENSITIVE download Created with Sketch. 897.76KB Share AVE Appendix 4C - Quarterly 22/07/19 PRICE SENSITIVE download Created with Sketch. 81.61KB Share AVE Ashland purchases manufacturing rights for Vital ET and TPM 20/06/19 PRICE SENSITIVE download Created with Sketch. 66.02KB Share AVE Appendix 4C - Quarterly 30/04/19 PRICE SENSITIVE download Created with Sketch. 182KB Share AVE Changes to Leadership Team 27/03/19 PRICE SENSITIVE download Created with Sketch. 67.86KB Share AVE Appendix 4E - Preliminary Final Report 28/02/19 PRICE SENSITIVE download Created with Sketch. 432.38KB Share AVE FDA meeting provides guidance for TPM/Oxymorphone patch 17/01/19 PRICE SENSITIVE download Created with Sketch. 119.83KB Share AVE Reinstatement to Offical Quotation 19/12/18 PRICE SENSITIVE download Created with Sketch. 210.31KB Share AVE Phosphagenics and Mylan Agree Settlement 19/12/18 PRICE SENSITIVE download Created with Sketch. 250.08KB Share AVE Suspension from Official Quotation 12/12/18 PRICE SENSITIVE download Created with Sketch. 621.36KB Share AVE Trading Halt 10/12/18 PRICE SENSITIVE download Created with Sketch. 612.82KB Share AVE Phosphagenics Arbitration Award Issued 12/11/18 PRICE SENSITIVE download Created with Sketch. 325.91KB Share AVE Receipt of R&D Tax Incentive 08/11/18 PRICE SENSITIVE download Created with Sketch. 229.73KB Share AVE Response to ASX Price Query 26/10/18 PRICE SENSITIVE download Created with Sketch. 526.3KB Share AVE Phosphagenics Receives Further Arbitration Process Update 23/10/18 PRICE SENSITIVE download Created with Sketch. 335.2KB Share AVE Phosphagenics Licensing Agreement Update 10/09/18 PRICE SENSITIVE download Created with Sketch. 246.64KB Share AVE Half Year Accounts 13/08/18 PRICE SENSITIVE download Created with Sketch. 1.39MB Share AVE AGM Chairman's Address and CEO Presentation 25/05/18 PRICE SENSITIVE download Created with Sketch. 720.65KB Share
0.4¢
(20min delay)
